Treatment patterns and survival outcomes in patients with non-metastatic early-onset pancreatic cancer

Figure 1 Patient selection.

Figure 2 Overall survival of patients. A: Overall survival (OS) of 277 patients with non-metastatic early-onset pancreatic cancer; B: OS in patients with localized and locally advanced disease.

Figure 3 Treatment outcomes in localized and locally advanced disease. A: Overall survival (OS) with surgery alone and adjuvant therapy (AT)/neoadjuvant therapy (NAT) in patients with localized disease; B: Disease-free survival with surgery alone and AT/NAT in patients with localized disease; C: OS with chemotherapy, radiotherapy-based combination therapy (RCT), and surgery in patients with locally advanced disease; D: Progression-free survival with chemotherapy, RCT, and surgery in patients with locally advanced disease. RCT: Radiotherapy-based combination therapy.

Figure 4 Survival in patients with postoperative recurrence. A: Overall survival (OS) in patients with regional recurrence and distant metastasis; B: Treatment outcome with chemotherapy, radiotherapy-based combination treatment (RCT), and supportive therapy in patients with regional recurrence; C: Treatment outcome with chemotherapy, RCT, and supportive therapy in patients with distant metastasis. RCT: Radiotherapy-based combination therapy.